Compare · FONR vs OM
FONR vs OM
Side-by-side comparison of Fonar Corporation (FONR) and Outset Medical Inc. (OM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FONR and OM operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- OM is the larger of the two at $1.64B, about 16.0x FONR ($102.2M).
- Over the past year, FONR is up 55.7% and OM is down 61.1% - FONR leads by 116.8 points.
- OM has been more active in the news (6 items in the past 4 weeks vs 3 for FONR).
- OM has more recent analyst coverage (13 ratings vs 0 for FONR).
- Company
- Fonar Corporation
- Outset Medical Inc.
- Price
- $18.84+0.16%
- $4.53-0.88%
- Market cap
- $102.2M
- $1.64B
- 1M return
- +1.54%
- +28.37%
- 1Y return
- +55.66%
- -61.13%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1981
- 2020
- News (4w)
- 3
- 6
- Recent ratings
- 0
- 13
Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Outset Medical Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Latest FONR
- Amendment: SEC Form SC 13E3/A filed by Fonar Corporation
- SEC Form DEFM14A filed by Fonar Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Fonar Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Fonar Corporation
- Amendment: SEC Form SC 13E3/A filed by Fonar Corporation
- SEC Form PRER14A filed by Fonar Corporation
- SEC Form SC 13E3 filed by Fonar Corporation
- SEC Form PREM14A filed by Fonar Corporation
- SEC Form DEFA14A filed by Fonar Corporation
- Fonar Corporation filed SEC Form 8-K: Results of Operations and Financial Condition
Latest OM
- SEC Form DEFA14A filed by Outset Medical Inc.
- SEC Form DEF 14A filed by Outset Medical Inc.
- SEC Form 4 filed by Elliott Derick A.
- SEC Form 3 filed by new insider Elliott Derick A.
- Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Outset Medical Names Derick Elliott as Executive Vice President of Commercial
- Amendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.
- Amendment: New insider Leonard Braden Michael claimed ownership of 1,902,201 shares (SEC Form 3)
- General Counsel Brottem John L. sold $9,521 worth of shares (2,842 units at $3.35), decreasing direct ownership by 8% to 32,935 units (SEC Form 4)
- Chair and CEO Trigg Leslie sold $11,259 worth of shares (3,361 units at $3.35), decreasing direct ownership by 3% to 102,342 units (SEC Form 4)